Epidemiological profile of patients with osteogenesis imperfecta assisted at a reference children's hospital in Brazil

Objective: To characterize the profile and care of patients with osteogenesis imperfecta (OI) treated at a reference hospital in southern Brazil. Method: This retrospective cross-sectional observational study analyzed secondary data from electronic medical records between 2010 and 2021. Data from pa...

Full description

Saved in:
Bibliographic Details
Published inCuadernos de educación y desarrollo Vol. 16; no. 10; p. e5790
Main Authors Puel, Alexia Nadine, Alves, Luene Bárbara Mendonça, Carvalho, Maria Eduarda de, Xavier, Hagos Nascimento, Sanada, Luciana Sayuri, Cebrian, Cinthia Faraco Martinez, Sonza, Anelise
Format Journal Article
LanguageEnglish
Published 04.10.2024
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: To characterize the profile and care of patients with osteogenesis imperfecta (OI) treated at a reference hospital in southern Brazil. Method: This retrospective cross-sectional observational study analyzed secondary data from electronic medical records between 2010 and 2021. Data from patients aged 0–22 years with a confirmed OI diagnosis who underwent care at a reference hospital. Results: 97 medical records were included. The mean age of the children was 11 ± 4.99 years, with a prevalence of males (51.8%). Most obtained the postnatal diagnosis and were classified as type I (50.9%). The number of fractures, orthopedic surgeries, and cycles of pamidronate were higher in type III subjects. As for access to medication, 88.54% were hospitalized for the administration of pamidronate and 32.29% for zoledronate. Independent walking and type I modified independent walking (walker) and type IV, and the use of a wheelchair and type III had an association (X2 = 67.832; p=0.000) between them. Conclusions: The profiles of the individuals in this study reflect the characteristics of the classic division of types I to IV. The reference center offers multidisciplinary care, access to specific drugs, and essential orthopedic surgeries to improve the quality of life of patients with osteogenesis imperfecta.
ISSN:1989-4155
1989-4155
DOI:10.55905/cuadv16n10-034